Early Detection of Pressure Ulcer Development Following Traumatic Spinal Cord Injury Using Inflammatory Mediators.

OBJECTIVE To identify changes in concentrations of inflammatory mediators in plasma and urine after traumatic spinal cord injury (SCI) and before the occurrence of a first pressure ulcer. DESIGN Retrospective; secondary analysis of existing data. SETTING Acute hospitalization and inpatient rehabilitation sites at a university medical center. PARTICIPANTS Individuals with a pressure ulcer and plasma samples (n=17) and individuals with a pressure ulcer and urine samples (n=15) were matched by age and plasma/urine sample days to individuals with SCI and no pressure ulcer (N=35). INTERVENTIONS Not applicable. MAIN OUTCOME MEASURES Plasma and urine samples were assayed in patients with SCI, capturing samples within 4 days after the SCI to a week before the formation of the first pressure ulcer. The Wilcoxon signed-rank test was performed to identify changes in the inflammatory mediators between the 2 time points. RESULTS An increase in concentration of the chemokine interferon-γ-induced protein of 10kd/CXCL10 in plasma (P<.01) and a decrease in concentration of the cytokine interferon-α in urine (P=.01) were observed before occurrence of a first pressure ulcer (∼4d) compared with matched controls. CONCLUSIONS Altered levels of inflammatory mediators in plasma and urine may be associated with pressure ulcer development after traumatic SCI. These inflammatory mediators should be explored as possible biomarkers for identifying individuals at risk for pressure ulcer formation.

[1]  M. Makhsous,et al.  Elevation in the Serum and Urine Concentration of Injury‐Related Molecules After the Formation of Deep Tissue Injury in a Rat Spinal Cord Injury Pressure Ulcer Model , 2010, PM & R : the journal of injury, function, and rehabilitation.

[2]  H. Keirstead,et al.  Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice. , 2007, Regenerative medicine.

[3]  M. Molinari,et al.  Pressure sores and blood and serum dysmetabolism in spinal cord injury patients , 2004, Spinal Cord.

[4]  J. Segal,et al.  Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. , 1997, Archives of physical medicine and rehabilitation.

[5]  T. Defloor,et al.  Patient stories of living with a pressure ulcer. , 2006, Journal of advanced nursing.

[6]  O. Bagasra,et al.  The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. , 1997, Cytokine & growth factor reviews.

[7]  C. Oomens,et al.  An in vitro Model System to Study the Damaging Effects of Prolonged Mechanical Loading of the Epidermis , 2006, Annals of Biomedical Engineering.

[8]  R. Diegelmann.  Excessive neutrophils characterize chronic pressure ulcers , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[9]  Qi Mi,et al.  Inducible Protein-10, a Potential Driver of Neurally Controlled Interleukin-10 and Morbidity in Human Blunt Trauma* , 2014, Critical care medicine.

[10]  S. Rossignol,et al.  Epidemiology of Traumatic Spinal Cord Injury , 2013 .

[11]  David J Margolis,et al.  Medical conditions as risk factors for pressure ulcers in an outpatient setting. , 2003, Age and ageing.

[12]  M. Devivo,et al.  Epidemiology of traumatic spinal cord injury: trends and future implications , 2012, Spinal Cord.

[13]  W. Tompkins.  Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[14]  W. Donovan,et al.  Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems. , 1999, Archives of physical medicine and rehabilitation.

[15]  I. Kushner,et al.  Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. , 2005, Archives of physical medicine and rehabilitation.

[16]  R. Groves,et al.  Recombinant human GM-CSF in the treatment of poorly healing wounds. , 2000, Advances in skin & wound care.

[17]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[18]  Schmidt Ja,et al.  Recombinant human GM-CSF in the treatment of poorly healing wounds. , 2000 .

[19]  Cees W J Oomens,et al.  Plasma variations of biomarkers for muscle damage in male nondisabled and spinal cord injured subjects. , 2012, Journal of rehabilitation research and development.

[20]  W. Pan,et al.  Selective increase in TNFα permeation across the blood–spinal cord barrier after SCI , 2003, Journal of Neuroimmunology.

[21]  Y. L. Lee,et al.  Cytokine chemokine expression in contused rat spinal cord , 2000, Neurochemistry International.

[22]  R. Carter,et al.  Risk of mortality after spinal cord injury: an 8-year prospective study. , 2009, Archives of physical medicine and rehabilitation.

[23]  N. Schneiderhan-Marra,et al.  Wound Fluid Diagnostics in Diabetic Foot Ulcers , 2011 .

[24]  D. Remick,et al.  Interleukin‐8 levels and activity in delayed‐healing human thermal wounds , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[25]  Ryan Insolera,et al.  IL-10 promotes neuronal survival following spinal cord injury , 2009, Experimental Neurology.

[26]  M. Beattie,et al.  Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats , 1997, Journal of neuroscience research.

[27]  J. Yoshida,et al.  Type I interferon inhibits astrocytic gliosis and promotes functional recovery after spinal cord injury by deactivation of the MEK/ERK pathway. , 2009, Journal of neurotrauma.

[28]  T. Joos,et al.  A novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations , 2012 .

[29]  P. Blumbergs,et al.  Early Expression and Cellular Localization of Proinflammatory Cytokines Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-&agr; in Human Traumatic Spinal Cord Injury , 2004, Spine.

[30]  R. Romero,et al.  CXCL10/IP-10: A missing link between inflammation and anti-angiogenesis in preeclampsia? , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[31]  W. Garner,et al.  Inflammatory mediators in wound healing. , 2003, The Surgical clinics of North America.

[32]  M. Guihan,et al.  Potentially modifiable risk factors among veterans with spinal cord injury hospitalized for severe pressure ulcers: a descriptive study , 2012, The journal of spinal cord medicine.

[33]  B. Choi,et al.  Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats. , 2014, Journal of neurosurgery. Spine.

[34]  O. Stojadinović,et al.  Clinical application of growth factors and cytokines in wound healing , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[35]  D. Langemo,et al.  National Pressure Ulcer Advisory Panel's updated pressure ulcer staging system. , 2007, Advances in skin & wound care.

[36]  O N Hausmann,et al.  Post-traumatic inflammation following spinal cord injury , 2003, Spinal Cord.

[37]  Kath M Bogie,et al.  Pressure ulcer management and research priorities for patients with spinal cord injury: consensus opinion from SCI QUERI Expert Panel on Pressure Ulcer Research Implementation. , 2011, Journal of rehabilitation research and development.

[38]  J. Stechmiller,et al.  Effect of Vacuum‐Assisted Closure Therapy on the expression of cytokines and proteases in wound fluid of adults with pressure ulcers , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[39]  W. Payne,et al.  Long-term outcome study of growth factor-treated pressure ulcers. , 2001, American journal of surgery.

[40]  E. Mazzon,et al.  Absence of endogenous interleukin‐10 enhances secondary inflammatory process after spinal cord compression injury in mice , 2009, Journal of neurochemistry.

[41]  Jacob Alex Klerman,et al.  Trends and Future Directions in Youth Labour Markets: Implications for Army Recruiting , 1993 .

[42]  Yun Ho Jang,et al.  Regulation of Wound Healing by Granulocyte-Macrophage Colony-Stimulating Factor after Vocal Fold Injury , 2013, PloS one.